These initial reports clarified the effects of CD137 in different conditions (i.e., cancer and autoimmunity) and suggested that the sCD137 was the missing link in understanding the dual effects of the mCD137/CD137L axis. The gene discussed is TNFRSF9; the disease is cancer.